title: Retrieval of critically ill adults using extracorporeal membrane oxygenation: an Australian experience.
abstract: OBJECTIVE
  A retrieval program was developed in New South Wales (NSW), Australia to provide extracorporeal membrane oxygenation support (ECMO) for the safe transport of adults with severe, acute respiratory or cardiac failure. We describe the development and results of this program and the impact of the 2009 H1N1 epidemic on this service.
  
  
  METHODS
  An observational study of all patients who were retrieved on ECMO support in NSW, from March 1, 2007 to June 1, 2010, was carried out.
  
  
  RESULTS
  Forty adult patients were retrieved on ECMO support (median age 34 years). The indications for retrieval were respiratory in 38 patients (of whom 16 were confirmed or suspected H1N1 cases) and cardiac in 2 patients. Two other patients died after referral but before ECMO support could be established. Patients were transported by road (n = 26, 65%), medical retrieval jet (n = 10, 25%) and helicopter (n = 4, 10%). The median retrieval distance was 250 km (range 12-1,960 km). Thirty-four patients (85%) survived to hospital discharge. Survival for respiratory indications was 87% (33/38 patients) and 50% (1/2 patients) for cardiac indications. There were no deaths or major morbidity associated with these retrievals.
  
  
  CONCLUSIONS
  Patients with very severe respiratory failure, which was considered to preclude conventional ventilation for safe transfer to tertiary centres, were managed by an ECMO referral and retrieval program in NSW and had a high rate of survival. This program also enhanced the capacity of the state to respond to a surge in demand for ECMO support due to the H1N1 epidemic, although the role of ECMO in respiratory failure is not yet well defined.
authors.affiliation: Department of Anaesthetics, Royal Prince Alfred Hospital, Sydney, Australia. pforrest@usyd.edu.au
authors.forename: P
authors.initials: P
authors.lastname: Forrest
authors.forename: J
authors.initials: J
authors.lastname: Ratchford
authors.forename: B
authors.initials: B
authors.lastname: Burns
authors.forename: R
authors.initials: R
authors.lastname: Herkes
authors.forename: A
authors.initials: A
authors.lastname: Jackson
authors.forename: B
authors.initials: B
authors.lastname: Plunkett
authors.forename: P
authors.initials: P
authors.lastname: Torzillo
authors.forename: P
authors.initials: P
authors.lastname: Nair
authors.forename: E
authors.initials: E
authors.lastname: Granger
authors.forename: M
authors.initials: M
authors.lastname: Wilson
authors.forename: R
authors.initials: R
authors.lastname: Pye
mesh_terms: D000328:Adult; D016638:Critical Illness / Q000453:epidemiology / Q000628:therapy*; D015199:Extracorporeal Membrane Oxygenation; D005260:Female; D006801:Humans; D008297:Male; D009517:New South Wales / Q000453:epidemiology; D017063:Outcome Assessment, Health Care; D012128:Respiratory Distress Syndrome / Q000628:therapy; D012189:Retrospective Studies; D016019:Survival Analysis